Clinical and laboratory features between anti‐ TIF1γ dermatomyositis with and without malignancy: 37 case series and a review

恶性肿瘤 医学 皮肌炎 内科学 乳腺癌 胃肠病学 队列 癌症 肌炎
作者
Keyun Tang,Hanlin Zhang,Xinyi Zhang,Hongzhong Jin
出处
期刊:Journal of Dermatology [Wiley]
卷期号:51 (12): 1646-1657 被引量:8
标识
DOI:10.1111/1346-8138.17426
摘要

We aimed to analyze the clinical profile and malignancy indicators in dermatomyositis (DM) with anti-transcriptional intermediary factor 1 antibody (anti-TIF1γ-Ab). A comparison was made between clinical information of anti-TIF1γ DM patients with and without malignancy. Additionally, a review of the literature on anti-TIF1γ DM and malignancy was conducted by searching PubMed and EMBASE databases. In our cohort of 37 patients, 27.0% (10/37) developed malignancy. The timeframe during which these 10 patients developed malignancy ranged from 21 months prior to the diagnosis of DM to 36 months following the diagnosis of DM. Specifically, one patient was diagnosed with breast cancer at the age of 36. Comparing the groups with and without malignancy, we found that age over 65 years (40% vs 7.4%, P = 0.035), a shorter duration from the onset of symptoms to the diagnosis of DM (2.5 vs 10 months, P = 0.003), and higher erythrocyte sedimentation rate (ESR) levels (23 vs 10 mm/h, P = 0.048) were found to be associated with an increased risk of malignancy. Conversely, the presence of Gottron's papules (63% vs 20%, P = 0.029) may suggest a lower likelihood of malignancy. The literature review revealed that the prevalence of myositis-associated malignancy was 40.7% (340/836), with variations ranging from 19% to 82.9% across different series. In summary, factors such as age over 65 years, a shorter duration between symptom onset and diagnosis of DM, and elevated ESR levels may indicate an increased risk of malignancy in anti-TIF1γ DM patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
公主发布了新的文献求助10
1秒前
Song完成签到,获得积分10
1秒前
李健的应助被Meiyu采纳,获得10
1秒前
秦知余发布了新的文献求助10
2秒前
3秒前
贪玩丑完成签到,获得积分10
3秒前
yl1111完成签到,获得积分10
4秒前
wdddr发布了新的文献求助20
4秒前
Gustav_Lebon发布了新的文献求助10
4秒前
乐乐的应助被gxy采纳,获得10
4秒前
5秒前
李健的粉丝团团长的应助被Song采纳,获得10
6秒前
榴莲爱美丽完成签到,获得积分10
7秒前
8秒前
英俊的铭的应助被贪玩丑采纳,获得10
8秒前
9秒前
ZZ发布了新的文献求助10
9秒前
小萝卜发布了新的文献求助10
9秒前
10秒前
FashionBoy的应助被ZhouJing采纳,获得10
11秒前
雇凶暗杀蛋饺完成签到,获得积分10
11秒前
经十路以东的应助被tom采纳,获得10
11秒前
丘比特的应助被qqqqqqqqqq采纳,获得10
12秒前
ERCPdoctor发布了新的文献求助100
13秒前
等风的拾荒者完成签到 ,获得积分10
14秒前
魔幻伟宸完成签到,获得积分10
15秒前
carol7298完成签到,获得积分10
15秒前
wellforever发布了新的文献求助10
15秒前
秦知余完成签到,获得积分20
17秒前
18秒前
斯文败类的应助被眼角流星采纳,获得10
19秒前
经十路以东的应助被00hello00采纳,获得10
19秒前
19秒前
火山完成签到,获得积分10
20秒前
21秒前
21秒前
情怀的应助被闪耀的启明星采纳,获得10
21秒前
LYB完成签到 ,获得积分10
21秒前
22秒前
syvshc的应助被00hello00采纳,获得10
22秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8194107
求助须知:如何正确求助?哪些是违规求助? 9580062
关于积分的说明 21869017
捐赠科研通 7793713
什么是DOI,文献DOI怎么找? 3437523
关于科研通互助平台的介绍 2560962
邀请新用户注册赠送积分活动 2484264